Chronic exposure to arsenic in drinking water can lead to resistance to antimonial drugs in a mouse model of visceral leishmaniasis.
about
Recent developments in drug discovery for leishmaniasis and human African trypanosomiasisArsenic exposure and outcomes of antimonial treatment in visceral leishmaniasis patients in Bihar, India: a retrospective cohort studyA Multiplatform Metabolomic Approach to the Basis of Antimonial Action and Resistance in Leishmania infantumChronic Arsenic Exposure and Risk of Post Kala-azar Dermal Leishmaniasis Development in India: A Retrospective Cohort StudyDrug resistance in eukaryotic microorganisms.Transmission potential of antimony-resistant leishmania field isolatesSterol 14α-demethylase mutation leads to amphotericin B resistance in Leishmania mexicana.Chronic arsenic exposure and microbial drug resistance.Treatment failure in leishmaniasis: drug-resistance or another (epi-) phenotype?The genetics of Leishmania virulence.Alice in microbes' land: adaptations and counter-adaptations of vector-borne parasitic protozoa and their hosts.Evaluating drug resistance in visceral leishmaniasis: the challenges.Arsenic silences hepatic PDK4 expression through activation of histone H3K9 methylatransferase G9aOral exposure to arsenic causes hearing loss in young people aged 12-29 years and in young mice.Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent.Characterisation of a Putative Glutamate 5- Kinase from Leishmania donovani.Antimony susceptibility of Leishmania isolates collected over a 30-year period in Algeria.Arsenic level in toenails is associated with hearing loss in humans
P2860
Q27011766-9FC3C23E-D0C8-4A41-A2A5-95FA32B917FAQ28543757-DC9A476C-B18A-490C-85DE-F97EFF342057Q28546448-BC070883-523A-4D9F-98AB-CA0CFAF54262Q28552931-99DDC70C-83E1-4683-82D2-B68F4C78634FQ30248243-DED1FCB8-DF1A-4C93-929D-D7C0F5463747Q34299023-CDDBCF37-BCEB-4DBC-99C1-60179DF9CE06Q36407342-45E733A1-793F-4F35-AF72-B726D2074D5EQ37377400-E5054B19-9A8A-4A5B-8DA7-786094FEF1C3Q38209866-C21F2D7C-EA36-409F-ABC7-1C6D5C2C7025Q38517526-1F176CDB-9481-47A4-866E-EDE7F826A83FQ38892717-EFB83245-3D50-4A64-B51F-8AE18EB2EF0BQ39014583-C894B73F-52AE-4A44-B800-6B62848112B9Q41879681-17159197-ED4E-4A8A-BDAD-7B2FC24A1504Q41995506-99FF186A-2B40-4AE4-A7E7-C62C7777DEE9Q52579703-04956A64-074E-4BEF-97CC-09073205A408Q54108724-33E795A8-777D-461A-8C57-DDA6D1B2AE04Q55200404-010675C7-E424-4572-8887-B72497462509Q57929084-CF2AD494-9293-4EDF-891E-2E2721D7859C
P2860
Chronic exposure to arsenic in drinking water can lead to resistance to antimonial drugs in a mouse model of visceral leishmaniasis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chronic exposure to arsenic in ...... del of visceral leishmaniasis.
@en
Chronic exposure to arsenic in ...... del of visceral leishmaniasis.
@nl
type
label
Chronic exposure to arsenic in ...... del of visceral leishmaniasis.
@en
Chronic exposure to arsenic in ...... del of visceral leishmaniasis.
@nl
prefLabel
Chronic exposure to arsenic in ...... del of visceral leishmaniasis.
@en
Chronic exposure to arsenic in ...... del of visceral leishmaniasis.
@nl
P2860
P50
P356
P1476
Chronic exposure to arsenic in ...... del of visceral leishmaniasis.
@en
P2093
Andrea Raab
Meghan R Perry
P2860
P304
19932-19937
P356
10.1073/PNAS.1311535110
P407
P577
2013-10-28T00:00:00Z